TFA
CRL icon

Transamerica Financial Advisors’s Charles River Laboratories CRL Stock Holding History

Transamerica Financial Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.54K Buy
20
+3
+18% +$534 ﹤0.01% 1142
2026
Q1 		$2.93K Sell
17
-1
-6% -$185 ﹤0.01% 1137
2025
Q4 		$3.59K Buy
18
+4
+29% +$726 ﹤0.01% 1018
2025
Q3 		$2.19K Buy
+14
New +$2.22K ﹤0.01% 1025

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Transamerica Financial Advisors's CRL Position: Q2 2026 in Review

Transamerica Financial Advisors increased its Charles River Laboratories (CRL) stake by 18% in Q2 2026, buying an estimated $534 and bringing the position to 20 shares worth $4.54K. The position accounts for ﹤0.01% of the portfolio, ranked #1142.

Transamerica Financial Advisors first reported a position in CRL in Q3 2025 and has held it in 4 quarters since. 568 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Transamerica Financial Advisors held 20 shares of Charles River Laboratories worth $4.54K as of Q2 2026.
  • Transamerica Financial Advisors bought 3 Charles River Laboratories shares in Q2 2026, an estimated $534.
  • Charles River Laboratories made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #1142 holding.
  • Transamerica Financial Advisors first reported a position in Charles River Laboratories in Q3 2025 and has held it in 4 quarters since.
  • 568 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.